(Q34064209)

English

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria (English)

1 reference

Europe PubMed Central

30 July 2017

multicenter clinical trial

0 references

multiple sclerosis

0 references

magnetic resonance imaging

0 references

methylprednisolone

1 reference

based on heuristic

inferred from title

author name string

Edan G

1

1 reference

Europe PubMed Central

30 July 2017

Miller D

2

1 reference

Europe PubMed Central

30 July 2017

Clanet M

3

1 reference

Europe PubMed Central

30 July 2017

Confavreux C

4

1 reference

Europe PubMed Central

30 July 2017

Lyon-Caen O

5

1 reference

Europe PubMed Central

30 July 2017

Lubetzki C

6

1 reference

Europe PubMed Central

30 July 2017

Brochet B

7

1 reference

Europe PubMed Central

30 July 2017

Berry I

8

1 reference

Europe PubMed Central

30 July 2017

Rolland Y

9

1 reference

Europe PubMed Central

30 July 2017

Froment JC

10

1 reference

Europe PubMed Central

30 July 2017

Cabanis E

11

1 reference

Europe PubMed Central

30 July 2017

Iba-Zizen MT

12

1 reference

Europe PubMed Central

30 July 2017

Gandon JM

13

1 reference

Europe PubMed Central

30 July 2017

Lai HM

14

1 reference

Europe PubMed Central

30 July 2017

Moseley I

15

1 reference

Europe PubMed Central

30 July 2017

Sabouraud O

16

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

1 February 1997

1 reference

Europe PubMed Central

30 July 2017

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

30 July 2017

62

1 reference

Europe PubMed Central

30 July 2017

112-118

1 reference

Europe PubMed Central

30 July 2017

2

1 reference

Europe PubMed Central

30 July 2017

describes a project that uses

magnetic resonance imaging

1 reference

based on heuristic

inferred from title

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

An open-trial evaluation of mitoxantrone in the treatment of progressive MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Suppression of experimental allergic encephalomyelitis by mitoxantrone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Cognitive change following MPTP exposure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

The efficacy of azathioprine in relapsing-remitting multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

EDMUS, a European database for multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Treatment of multiple sclerosis with mitoxantrone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

28 October 2018

Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

28 October 2018

Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

28 October 2018

Clinical safety and tolerance of mitoxantrone

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitoxantrone: an overview of safety and toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antitumor agent mitoxantrone binds cooperatively to DNA: evidence for heterogeneity in DNA conformation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regional suppression, therapy after onset and prevention of relapses in experimental allergic encephalomyelitis by mitoxantrone

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Controlled Trial of Mitoxantrone in Multiple Sclerosis: Serial MRI Evaluation at One Year

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noninvasive Assessment of Mitoxantrone Cardiotoxicity in Relapsing Remitting Multiple Sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JNNP.62.2.112

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34064209&oldid=1877326209"